跳至主要内容
临床试验/NCT03670160
NCT03670160已完成2 期

Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome

University of Tennessee Medical Center1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2018年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
25
试验地点
1
主要终点
Time From Initiation of Adjunctive Therapy Until Hospital Discharge

研究概览

简要总结

The purpose of this study is to compare clonidine versus phenobarbital as adjunctive therapy in those infants who have failed monotherapy with morphine sulfate for neonatal abstinence syndrome (NAS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
35 Weeks 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Infants greater than or equal to 35 weeks gestation age
  • Admitted to the neonatal intensive care unit
  • Failed monotherapy with morphine sulfate therapy

排除标准

  • Neonatal abstinence syndrome due to iatrogenic causes
  • Unable to take oral medications at any point during their treatment
  • Infants in the custody of the Department of Child Protective Services with no legal guardian identified at the time of enrollment

研究组 & 干预措施

Phenobarbital

Active Comparator

Phenobarbital loading dose 20mg/kg in 2 divided doses, then 5 mg/kg/day divided every 12 hours. Phenobarbital continued throughout the infants hospitalization.

干预措施: Phenobarbital (Drug)

Clonidine

Active Comparator

Clonidine 5 mcg/kg/day divided every 3 hours. Clonidine will be continued to achieve control of NAS symptoms. Clonidine may be weaned after successful discontinuation of oral morphine sulfate. Infants will not be discharged on clonidine.

干预措施: Clonidine (Drug)

结局指标

主要结局

Time From Initiation of Adjunctive Therapy Until Hospital Discharge

时间窗: From date of randomization until hospital discharge, up to 4 months

Number of days from initiation of adjunctive therapy until hospital discharge

次要结局

  • Readmission Rate(From date of randomization until 30 days after hospital discharge or discontinuation of phenobarbital, up to 6 months)
  • Length of Stay(From date of randomization until hospital discharge, up to 4 months)
  • Length of Oral Morphine Sulfate Therapy(From date of randomization until hospital discharge, up to 4 months)
  • Number of Patients Requiring Triple Therapy(From date of randomization until hospital discharge, up to 4 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验